Showing papers on "Business model published in 1980"
TL;DR: In this paper, the authors analyzed the changing pattern of advertisement strategy by Japanese business firms in the U.S. market and found that the Japanese advertisement strategy has passed sequentially through four stages: (1) Nationality-Supportive, (2) Product-Attributes, (3) Challenge and Responses, and (4) World Market-oriented advertisement.
Abstract: This article analyzes the changing pattern of advertisement strategy by Japanese business firms in the U.S. market. Taking the advertisement activities of four major industrial sectors that appeared in both Business Week and Newsweek during the 1965–1977 period as samples, this article has found that the Japanese advertisement strategy in the U.S. market has passed sequentially through the following four stages: (1) Nationality-Supportive, (2) Product-Attributes, (3) Challenge and Responses, and (4) World Market-oriented advertisement.
23 citations
11 citations
TL;DR: In this article, the authors make a case that accounting is a professional function in which activities depend on the needs of those business groups it serves, and that as the information needs of these separate national business groups converge, there will be precipitated a parallel growth of an internationalized accounting community.
Abstract: This paper makes a case that accounting is a professional function in which activities depend on the needs of those business groups it serves. As the information needs of these separate national business groups converge, there will be precipitated a parallel growth of an internationalized accounting community. This study investigates two hypotheses about the international linkage between acounting practices and the information needs of the financial community.
8 citations
TL;DR: "Every pill has a story, and before it got to a medicine cabinet, that pill had to pass the scrutiny of scientists toiling in labs, and go on to generate billions in profit.
Abstract: \"Every pill has a story. Before it got to a medicine cabinet, that pill had to pass the scrutiny of scientists toiling in labs. It had to win confidence in business meetings and prove itself safe to government regulators. Along the way, that pill could cost $1 billion or more in investment, and go on to generate billions in profit. That path, in more technical terms, is called life science commercialization, and it drives major sectors of the U.S. economy.\" according to a Biology Professor and Management Professor who teamed up to develop a business of science course at Wheaton College [1].
01 Jun 1980